Dr. Emily Mata
Pharmacist
3500 W Wheatland Rd, Dallas
Texas, 75237-3460
214-947-6154 Dr. Emily Mata is a pharmacist in Dallas, Texas. Patients can reach her at 3500 W Wheatland Rd, Dallas or contact her on 214-947-6154. Active license number of Dr. Emily Mata is 72640 for Pharmacist in Texas.
Dr. Emily Mata is
Complete Profile:
Dr. Emily Mata speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
| Name: | Dr. Emily Mata |
| Specialization: | Pharmacist |
| Credentials: | PHARMD |
| Gender: | Female |
| Location: | 3500 W Wheatland Rd, Dallas,
Texas, 75237-3460 |
| Phone: | 214-947-6154 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Emily Mata are as mentioned below.
| NPI Number: | 1134067788 |
| NPI Enumeration Date: | 24 Mar, 2026 |
| NPI Last Update On: | 24 Mar, 2026 |
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Emily Mata are as mentioned below.
| Specialization | License Number | State | Status | |
| Pharmacist | 72640 | Texas | Primary | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 3500 W Wheatland Rd,
Dallas, Texas |
| Zip: | 75237-3460 |
| Phone Number: | -- |
Patients can reach Dr. Emily Mata at
3500 W Wheatland Rd, Dallas, Texas or can
call on phone at 214-947-6154.
Comments/ Reviews:
Read all the reviews posted for Dr. Emily Mata below. You may also share your own experience with Dr. Emily Mata. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 June, 2026.